OR WAIT null SECS
Feliza Mirasol is the science editor for Pharmaceutical Technology and Pharmaceutical Technology Europe.
May 03, 2023
The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.
The use of smart tools in early drug discovery can have an impact on downstream phases of drug development.
May 02, 2023
INTERPHEX was back in full swing with Keynote sessions highlighting cutting-edge technologies that are setting the stage for the bio/pharma industry’s future.
April 18, 2023
Following disruption in the bio/pharmaceutical supply chain as a result of the COVID pandemic, the outsourcing industry has learned to adapt and push forward in a climate that is dynamically different.
April 15, 2023
The recent success of mRNA vaccines has opened the door for further and future development of nucleic acid-based therapies.
April 14, 2023
Avid Bioservices has launched new CGMP mammalian cell manufacturing suites at its Myford, Calif., facility.